Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ('ugly') locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)

Authors :: Berg, K van den
Schaap, D.P
Voogt, E.L.K.
Buffart, T.E.
Verheul, H.M.W.
Groot, J.W.B. de
Wilt, J.H.W. de
Peters, N.A.J.B.
Rutten, H. J. T.
Burger, J.W.A.
Berg, K van den
Schaap, D.P
Voogt, E.L.K.
Buffart, T.E.
Verheul, H.M.W.
Groot, J.W.B. de
Wilt, J.H.W. de
Peters, N.A.J.B.
Rutten, H. J. T.
Burger, J.W.A.
Source :: BMC Cancer; 1471-2407; 1; 22; 957; ~BMC Cancer~~~~~1471-2407~1~22~~957
Publication Year :: 2022
Abstract: Contains fulltext : 253728.pdf (Publisher’s version ) (Open Access)

Database :: OAIster
Journal :: BMC Cancer; 1471-2407; 1; 22; 957; ~BMC Cancer~~~~~1471-2407~1~22~~957
Publication Type :: Electronic Resource
Accession number :: edsoai.on1366769669
Document Type :: Electronic Resource

Tools